Correct Answer: D. Microscopic agglutination test
The clinical presentation of fever, icterus, conjunctival suffusion, and hematuria for 15 days is pathognomonic for leptospirosis, specifically the icteric form (Weil's disease). Conjunctival suffusion without exudate is a hallmark sign distinguishing leptospirosis from other febrile illnesses. At 15 days of illness, the patient is in the immune phase (after day 7–10), when IgM and IgG antibodies are detectable. The microscopic agglutination test (MAT) is the gold standard serological test for leptospirosis diagnosis. MAT can identify the serovar and provides both diagnostic and epidemiological information. A four-fold rise in titre between acute and convalescent sera, or a single titre ≥1:400 in endemic areas (India is endemic for leptospirosis), confirms diagnosis. MAT is more specific and sensitive than other agglutination methods and is the reference standard recommended by WHO and Indian guidelines (ICMR). In the immune phase, MAT becomes positive and remains the most reliable test for confirming leptospirosis.
Why the other options are wrong
A. Weil felix reaction — Weil–Felix is a non-specific heterophile agglutination test used for rickettsial infections (spotted fever, typhus), not leptospirosis. It detects antibodies against Proteus bacteria that cross-react with rickettsial antigens. Leptospira does not trigger Weil–Felix positivity. This is a classic NBE trap pairing rickettsial serology with febrile illnesses. B. Widal test — Widal test detects antibodies against Salmonella typhi and paratyphi (enteric fever), not Leptospira. Although both present with fever and can cause jaundice, conjunctival suffusion is absent in typhoid and is a discriminating sign for leptospirosis. Widal is the DOC for enteric fever, not leptospirosis. C. Paul Bunnell test — Paul–Bunnell test detects heterophile antibodies in infectious mononucleosis (EBV infection), not leptospirosis. The test is specific for EBV and has no role in diagnosing bacterial infections. This option exploits confusion between different serological tests for different pathogens.
High-Yield Facts
- Leptospirosis presents with biphasic fever: leptospiremic phase (days 1–7) and immune phase (days 7–30); serological tests are positive only in immune phase.
- Conjunctival suffusion without exudate is a pathognomonic sign of leptospirosis, absent in typhoid and rickettsial infections.
- Microscopic agglutination test (MAT) is the gold standard; a titre ≥1:400 or four-fold rise between acute and convalescent sera confirms diagnosis.
- Icteric leptospirosis (Weil's disease) occurs in 5–10% of cases and carries 5–15% mortality; hematuria and jaundice indicate severe disease.
- India is endemic for leptospirosis; occupational exposure (farmers, slum dwellers, sewage workers) and monsoon season increase risk.
Mnemonics
LEPT for Leptospirosis Diagnosis Leptospiremic phase (days 1–7) → culture/PCR positive; Early immune phase (days 7–10) → MAT becomes positive; Peak antibodies (days 10–30) → MAT is gold standard; Titre ≥1:400 or four-fold rise = diagnosis. Use this to remember when to order MAT (after day 7). Conjunctival Suffusion = Leptospirosis Conjunctival suffusion WITHOUT exudate is the discriminating clinical sign for leptospirosis. Memorize: 'Suffusion = Leptospira' to rule out typhoid (no suffusion) and rickettsial infections (exudate present).
NBE Trap
NBE pairs leptospirosis with other febrile illnesses (typhoid, rickettsial fever) and offers serology tests for each (Widal, Weil–Felix) to exploit confusion between serological tests. The discriminating sign—conjunctival suffusion—combined with the 15-day timeline (immune phase) should anchor the diagnosis to MAT.
Clinical Pearl
In monsoon-endemic India, any patient presenting with fever, jaundice, and conjunctival suffusion should raise suspicion for leptospirosis. MAT ordered after day 7 of illness will confirm diagnosis and guide supportive care (dialysis, vasopressor support) in severe icteric cases, which carry high mortality if untreated.
_Reference: Jawetz, Melnick & Adelberg's Medical Microbiology Ch. 28 (Leptospira); ICMR guidelines on leptospirosis diagnosis and management_